Modern approaches to multiple sclerosis.
作者信息
Wilson Martin
机构信息
The Walton Centre Foundation Trust, Liverpool.
出版信息
Clin Med (Lond). 2011 Aug;11(4):361-3. doi: 10.7861/clinmedicine.11-4-361.
Abstract
摘要
相似文献
1
Modern approaches to multiple sclerosis.多发性硬化症的现代治疗方法。
Clin Med (Lond). 2011 Aug;11(4):361-3. doi: 10.7861/clinmedicine.11-4-361.
2
Diagnosis and treatment of multiple sclerosis.多发性硬化症的诊断与治疗
Acta Neurol Scand Suppl. 2008;188:12-21. doi: 10.1111/j.1600-0404.2008.01026.x.
3
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: yes.我们即将在未来 10 年内治愈多发性硬化症，尽管我们不知道其病因：是的。
Mult Scler. 2012 Jun;18(6):782-3. doi: 10.1177/1352458512446521.
4
We are about to cure MS in the next 10 years, even though we do not know its cause: no.我们将在未来10年内治愈多发性硬化症，尽管我们还不知道其病因：不。
Mult Scler. 2012 Jun;18(6):784-5. doi: 10.1177/1352458512446522.
5
Multiple Sclerosis.多发性硬化症。
Ann Intern Med. 2021 Jun;174(6):ITC81-ITC96. doi: 10.7326/AITC202106150. Epub 2021 Jun 8.
6
Therapeutic advances in pediatric multiple sclerosis.小儿多发性硬化症的治疗进展
J Pediatr. 2013 Sep;163(3):631-7. doi: 10.1016/j.jpeds.2013.04.028. Epub 2013 May 30.
7
Guideline for the diagnosis and management of multiple sclerosis: a Southern African perspective.多发性硬化症的诊断和管理指南：南非观点。
S Afr Med J. 2013 Jun 5;103(9 Suppl 3):670-91. doi: 10.7196/samj.7124.
8
Myths & facts ... about multiple sclerosis.关于多发性硬化症的误解与事实……
Nursing. 1999 Aug;29(8):25. doi: 10.1097/00152193-199908000-00012.
9
[Multiple sclerosis].[多发性硬化症]
Rev Prat. 2009 May 20;59(5):695-701.
10
Therapeutic options in multiple sclerosis: five new things.多发性硬化症的治疗选择：五件新事物。
Neurology. 2010 Nov 2;75(18 Suppl 1):S22-7. doi: 10.1212/WNL.0b013e3181fb3676.
本文引用的文献
1
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.根据关键性 IFNB-1b 试验 16 年后的原始治疗组的临床结局分析。
J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):907-12. doi: 10.1136/jnnp.2009.204123. Epub 2010 Jun 19.
2
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.多发性硬化症风险分担计划：与历史对照进行临床队列研究的两年结果
BMJ. 2009 Dec 2;339:b4677. doi: 10.1136/bmj.b4677.
3
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.首次临床事件提示多发性硬化后早期使用β-1b干扰素治疗的长期效果：3期BENEFIT试验的5年积极治疗延长期
Lancet Neurol. 2009 Nov;8(11):987-97. doi: 10.1016/S1474-4422(09)70237-6. Epub 2009 Sep 10.
4
Secondary progressive multiple sclerosis: current knowledge and future challenges.继发进展型多发性硬化症：当前认知与未来挑战
Lancet Neurol. 2006 Apr;5(4):343-54. doi: 10.1016/S1474-4422(06)70410-0.
5
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.多发性硬化症病理学中的轴突损失：对理解该疾病进展期的影响
J Neurol Sci. 2003 Feb 15;206(2):165-71. doi: 10.1016/s0022-510x(02)00069-2.
6
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.多发性硬化症推荐诊断标准：国际多发性硬化症诊断小组指南
Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032.
Zotero 插件